Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol plus esketamine versus propofol plus alfentanil for sedation during ERCP/EUS
NL-OMON22136Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in Hepatobiliary disorders and Gallbladder and biliary diseases comparing Propofol + esketamine with Propofol + alfentanil (2 arms). Primary endpoints: Total propofol dosage, Recovery time and 2 more. Started Dec 2015; status: completed.
02
Drugs
propofolesketaminealfentanil
03
Conditions
Hepatobiliary disordersGallbladder and biliary diseases
Beyond the preview
Go deeper on NL-OMON22136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22136.